IASO Biotherapeutics

About:

IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

Website: http://www.iasobio.com/

Top Investors: Hillhouse Investment, Innovent Biologics, CDH Investments, Co-Stone Venture Capital, GL Ventures LLC

Description:

IASO Biotherapeutics (IASO BIO) is a Nanjing-based biopharmaceutical company focused on the discovery, development and commercialization of cell therapies in the field of oncology.

Total Funding Amount:

$242M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2017-01-01

Contact Email:

lu.song(AT)iasobio.com

Founders:

Xuefei Huang

Number of Employees:

251-500

Last Funding Date:

2024-07-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai